Gentex posts Q4 and full-year 2025 results

Gentex Corporation filed a current report to make investors aware that it has released its latest financial results.

(Moderate)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

Gentex Corporation filed a current report to make investors aware that it has released its latest financial results. The company issued a news release covering its fourth quarter and full year ended December 31, 2025, dated January 30, 2026.

The news release is provided as Exhibit 99.1 and is being furnished under the rules for results of operations and financial condition, rather than filed for liability purposes under Section 18 of the Exchange Act. The report is signed on behalf of Gentex by Kevin C. Nash, Vice President - Finance and Chief Financial Officer.

8-K Event Classification

2 items: 2.02, 9.01

2 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Gentex Corporation (GNTX) disclose in this 8-K filing?

Gentex Corporation disclosed that it issued a news release announcing its financial results for the fourth quarter and full year ended December 31, 2025. The release, dated January 30, 2026, is included with the filing as Exhibit 99.1 for investor reference.

Which period do the latest Gentex (GNTX) financial results cover?

The latest Gentex financial results cover the fourth quarter and the full year ended December 31, 2025. These results are summarized in a news release dated January 30, 2026, which is attached to the filing as Exhibit 99.1 for investors to review.

How are Gentex’s (GNTX) 2025 results presented in this disclosure?

Gentex’s 2025 results are presented through a separate news release that is furnished as Exhibit 99.1. The company explicitly states this information is furnished, not filed under Section 18 of the Exchange Act, affecting how it is treated for certain liability purposes.

Who signed the Gentex (GNTX) 8-K reporting the 2025 results release?

The 8-K is signed on behalf of Gentex Corporation by Kevin C. Nash, who serves as Vice President - Finance and Chief Financial Officer. His signature indicates he is the duly authorized officer executing the report for the company under Exchange Act requirements.

What exhibit is attached to Gentex’s (GNTX) 8-K about 2025 results?

The filing includes one key exhibit: Exhibit 99.1, described as a News Release dated January 30, 2026. This exhibit contains the detailed financial results for Gentex’s fourth quarter and full year ended December 31, 2025, referenced in the main body of the report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 01/30/2026 - 08:00 AM EST

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report: January 30, 2026

GENTEX CORPORATION

(Exact name of registrant as specified in its charter)


Michigan	0-10235	38-2030505
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

600 North Centennial Street
Zeeland
Michigan		49464
(Address of principal executive offices)		(Zip Code)

Registrant's telephone number, including area code: (616) 772-1800

_____________________________________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.06 per share	GNTX	NASDAQ Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Section 2. Financial Information

Item 2.02 Results of Operations and Financial Condition.

(a)On January 30, 2026, Gentex Corporation issued a news release announcing financial results for the fourth quarter and year ended December 31, 2025. A copy of the news release is attached as Exhibit 99.1 to the Form 8-K.

The information in this Form 8-K and the attached Exhibit shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

Section 9. Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits.

(d) Exhibit

99.1 – News Release Dated January 30, 2026.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: January 30, 2026

GENTEX CORPORATION

(Registrant)

By /s/ Kevin C. Nash

Kevin C. Nash

Its Vice President - Finance and Chief Financial Officer

EXHIBIT INDEX

99.1 News Release Dated January 30, 2026

Source: View Original Filing on SEC EDGAR